Head-to-head for moms
Noom vs Hims & Hers
Noom and Hims & Hers both offer GLP-1 telehealth to mothers, but they make different trade-offs on family-budget value, clinical oversight, price and access. Here they are side-by-side on the Editors' Rating — our six-factor rubric for mothers.
Noom
Ranked #7 · Grade B−
Best for: Mothers already invested in Noom's habit-and-psychology approach who want a medication option under the same roof.
Visit NoomHims & Hers
Higher scoreRanked #6 · Grade B
Best for: Mothers who want a familiar, app-driven consumer brand with an explicit women's entrance and a sema price they can see before signing up.
Visit Hims & HersThe verdict
Hims & Hers edges out Noom on the Editors' Rating, 84 to 82 (B vs B−). Mothers who want a familiar, app-driven consumer brand with an explicit women's entrance and a sema price they can see before signing up.
Noom is still a genuine option — the behavior-change app that most mothers have already met, now with a medication arm bolted on — the psychology is its real product, and the GLP-1 is the newer, quieter half. Weigh the six factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | Noom | Hims & Hers |
|---|---|---|
| Editors' Rating | 82/100 · B− | 84/100 · B |
| Overall rank | #7 | #6 |
| Semaglutide | Not disclosed | $165/mo |
| Tirzepatide | Not disclosed | Not disclosed |
| Coverage | Multi-state | All 50 states |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Injection only | Yes |
Noom
Ranked #7 · Grade B−
What we like
- Best-in-class behavior-change and habit coaching
- Works toward brand coverage through its medical arm
- A familiar interface many parents already use daily
The caveats
- GLP-1 pricing and access aren't clearly disclosed up front
- The medical program feels secondary to the app
- Availability and med options vary by state and plan
Hims & Hers
Ranked #6 · Grade B
What we like
- Explicit women-focused (Hers) positioning and broad brand trust
- Nationwide, with a slick app and simple onboarding
- Discloses a monthly semaglutide price up front, and offers an oral route
The caveats
- Tirzepatide pricing isn't consistently disclosed
- Limited hormonal or maternal depth behind the branding
- Volume-first model; ongoing clinical touch is light
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes an Editors' Rating. Pricing, states and verification reflect each provider's public disclosures at last review; the Editors' Rating is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing Noom and Hims & Hers against other providers we review for mothers.
Or browse the full comparison hub.